Morgan Stanley Ice Cure Medical Ltd. Transaction History
Morgan Stanley
- $1.35 Trillion
- Q3 2024
A detailed history of Morgan Stanley transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Morgan Stanley holds 6,069 shares of ICCM stock, worth $7,464. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,069
Previous 6,069
-0.0%
Holding current value
$7,464
Previous $4,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ICCM
# of Institutions
15Shares Held
185KCall Options Held
0Put Options Held
0-
Ubs Group Ag59.9KShares$73,6690.0% of portfolio
-
Xtx Topco LTD London, X026.3KShares$32,3620.0% of portfolio
-
Geode Capital Management, LLC Boston, MA25.6KShares$31,4380.0% of portfolio
-
Two Sigma Investments, LP New York, NY18.5KShares$22,7850.0% of portfolio
-
Virtu Financial LLC New York, NY14.6KShares$17,9290.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $45.3M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.